-
-
-
-
-
-
-
Johnson & Johnson submits FDA application for psoriasis drug icotrokinra
-
-
-
-
-
-
-
AstraZeneca's TAGRISSO plus chemotherapy extends survival in lung cancer
-
-
-
-
-
-
-
Alkermes reports positive phase 2 trial results for narcolepsy drug
-
-
-
-
-
-
-
U.K. approves ARS Pharmaceuticals' needle-free epinephrine nasal spray
-
-
-
-
-
-
-
Dexcom (DXCM) Removes Certain Dexcom G6, G7, ONE, and ONE+ Receivers Due to Speaker Malfunction
-
-
-
-
-
-
-
Asia Broadband receives phase 2 equipment for Mexico facility
-
-
-
-
-
-
-
SK bioscience submits application for adjuvanted flu vaccine trial
-
71,245 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.